Bio-medically active zinc oxide nanoparticles synthesized by using extremophilic actinobacterium, Streptomyces sp. (MA30) and its characterization
Source abstract
Abstract
The present study describes the synthesis of zinc oxide nanoparticles (ZnO-NPs) using an extremophilic actinobacterial cell-free extract, supplied with aqueous zinc acetate solution. Crystalline nature, morphological features, and polydispersed nanoparticles size (15-30 nm) were identified by X-ray diffraction (XRD), atomic force and electron microscopic analysis with dynamic light scattering (DLS) study. The interaction between biomolecules and ZnO-NPs was analyzed using Fourier transform infra-red spectroscopy (FT-IR). Furthermore antibacterial, antioxidant activities, and cell viability test of ZnO-NPs were systematically evaluated. The present study opens a new avenue for the actinobacterial synthesis of oxide nanoparticles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Advanced Nanomaterials in Catalysis · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Actinobacterial Research Laboratory, Department of Microbiology, School of Biosciences, Periyar University, Salem, India
Funding
Department of Science and Technology, Ministry of Science and Technology
References (32)
Show source-provided references
1. Akhtar MJ · Int J Nanomedicine · 2012 · 7 · 845
2. 10.1016/j.powtec.2011.06.02810.1016/j.powtec.2011.06.028 ↗
3. Ben-Slama I · J Nanomed Nanotechnol · 2015 · 6 · 3
4. 10.1021/nl052326h10.1021/nl052326h ↗
5. Carmichael J · Cancer Res · 1987 · 47 · 936
6. Divya MJ · Res J Pharm Biol Chem · 2013 · 4 · 1137
7. Divyapriya S · World J Pharm Pharm Sci · 2014 · 3 · 1635
8. 10.1016/j.sjbs.2015.05.01610.1016/j.sjbs.2015.05.016 ↗
9. 10.1186/1477-3155-3-810.1186/1477-3155-3-8 ↗
10. 10.1016/j.jphotobiol.2013.07.01010.1016/j.jphotobiol.2013.07.010 ↗
11. 10.1111/j.1753-4887.1997.tb06100.x10.1111/j.1753-4887.1997.tb06100.x ↗
12. 10.1088/0957-4484/19/29/29510310.1088/0957-4484/19/29/295103 ↗
13. 10.1016/j.saa.2015.02.04110.1016/j.saa.2015.02.041 ↗
14. 10.1016/S1995-7645(11)60164-810.1016/S1995-7645(11)60164-8 ↗
15. 10.1007/s11051-008-9419-710.1007/s11051-008-9419-7 ↗
16. 10.1016/j.biomaterials.2010.02.06810.1016/j.biomaterials.2010.02.068 ↗
17. 10.1016/j.bmcl.2014.07.02310.1016/j.bmcl.2014.07.023 ↗
18. 10.1177/074823371142047310.1177/0748233711420473 ↗
19. Patel Rajesh M · J Adv Pharm Edu Res (JAPER) · 2011 · 1 · 52
20. Radhakrishnan M · Malay Appl Biol · 2007 · 36 · 59
21. 10.1016/j.jtemb.2015.05.00510.1016/j.jtemb.2015.05.005 ↗
22. 10.1063/1.274232410.1063/1.2742324 ↗
23. 10.1186/1477-3155-2-310.1186/1477-3155-2-3 ↗
24. 10.1016/j.ijpharm.2012.04.06910.1016/j.ijpharm.2012.04.069 ↗
25. Shirley AD · Dig J Nanomater Biostruct · 2010 · 5 · 447
26. Sinha S · J Appl Biosci · 2009 · 19 · 1113
27. 10.1016/S0306-9877(03)00026-410.1016/S0306-9877(03)00026-4 ↗
28. Taccola L · Int J Nanomedicine · 2011 · 6 · 1129
29. 10.1016/j.matlet.2013.03.09010.1016/j.matlet.2013.03.090 ↗
30. 10.1021/nn800511k10.1021/nn800511k ↗
31. 10.1016/S1466-6049(01)00197-010.1016/S1466-6049(01)00197-0 ↗
32. 10.1016/j.pnsc.2008.01.02610.1016/j.pnsc.2008.01.026 ↗